Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 2026, Online, from 8 October 2026, 15:00 (CEST) to 8 October 2026, 16:00 (CEST)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - November 2026, Online, from 12 November 2026, 15:00 (CET) to 12 November 2026, 16:00 (CET)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - December 2026, Online, from 10 December 2026, 15:00 (CET) to 10 December 2026, 16:00 (CET)

Human papillomavirus (HPV)

Applying for orphan designation

Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Date of authorisation: 02/06/2025, Revision: 3, Status: Authorised

Procedural advice for orphan medicinal product designation: Guidance for sponsors

Regulatory Procedure Management in IRIS roadmap

Chapter 3.II: XEVPRM detailed user guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA

ACT EU webinar on draft guidance on the conduct of clinical trials during public health emergencies, Online, from 8 April 2026, 10:00 (CEST) to 8 April 2026, 11:30 (CEST)